Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jan 18:11:839851.
doi: 10.3389/fcimb.2021.839851. eCollection 2021.

Editorial: Cutaneous Leishmaniasis: Exploring Pathogenesis and Immunomodulatory Approaches

Wander Rogério Pavanelli  1 , Izabel Galhardo Demarchi  2
Affiliations
Editorial

Editorial: Cutaneous Leishmaniasis: Exploring Pathogenesis and Immunomodulatory Approaches

Wander Rogério Pavanelli et al. Front Cell Infect Microbiol. .
No abstract available

Keywords: Leishmania; antiprotozoal agents; immunomodulation effect; immunomodulatory agent; parasite; tegumentary leishmaniasis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Cutaneous Leishmaniasis: Exploring Pathogenesis and Immunomodulatory Approaches

References

    1. Berbert T. R. N., de Mello T. F. P., Nassif P. W., Mota C. A., Silveira A. V., Duarte G. C., et al. (2018). Pentavalent Antimonials Combined With Other Therapeutic Alternatives for the Treatment of Cutaneous and Mucocutaneous Leishmaniasis: A Systematic Review. Dermatol. Res. Pract. 2018, 9014726. doi: 10.1155/2018/9014726 - DOI - PMC - PubMed
    1. Cabral F. V., Souza T. H. D. S., Sellera F. P., Fontes A., Ribeiro M. S. (2021). Towards Effective Cutaneous Leishmaniasis Treatment With Light-Based Technologies. A Systematic Review and Meta-Analysis of Preclinical Studies. J. Photochem. Photobiol. B. 221, 112236. doi: 10.1016/j.jphotobiol.2021.112236 - DOI - PubMed
    1. Kaye P. M., Cruz I., Picado A., Van Bocxlaer K., Croft S. L. (2020). Leishmaniasis Immunopathology-Impact on Design and Use of Vaccines, Diagnostics and Drugs. Semin. Immunopathol. 42 (3), 247–264. doi: 10.1007/s00281-020-00788-y - DOI - PubMed
    1. Kaye P., Scott P. (2011). Leishmaniasis: Complexity at the Host-Pathogen Interface. Nat. Rev. Microbiol. 9 (8), 604–615. doi: 10.1038/nrmicro2608 - DOI - PubMed
    1. Pinart M., Rueda J. R., Romero G. A., Pinzón-Flórez C. E., Osorio-Arango K., Maia-Elkhoury A. N. S., et al. (2020). Interventions for American Cutaneous and Mucocutaneous Leishmaniasis. Cochrane Database Syst. Rev. 8 (8), CD004834. doi: 10.1002/14651858.CD004834.pub3 - DOI - PMC - PubMed

Publication types

LinkOut - more resources